Todos os estudos
RecrutamentoFase I e Fase II (Integrada) - Primeira administração em humanosIntervencionista

A phase I/II, multicenter, randomized, double-blind, placebo within-patient controlled, first-in-human (FIH) Proof of Concept (PoC) study to evaluate the safety and efficacy of topically applied SXR1096 cream in patients with Netherton syndrome (NS)

This research is a trial into a new cream, SXR1096, for people who have Netherton syndrome, a condition that affects the skin. It's the very first time this cream will be tried in humans. The main goals are to carefully check if the cream is safe to use and if it helps make the skin condition better. We'll be comparing the new cream to a 'dummy' cream (placebo) which doesn't contain any medicine, to see if the new cream works better. We'll also be looking at how the cream affects symptoms like itching, redness, and flaking of the skin. This will help us understand if SXR1096 could be a helpful new treatment option.

Em resumo

Status
Recrutamento
Fase
Fase I e Fase II (Integrada) - Primeira administração em humanos
Patrocinador
Sixera Pharma AB
Meta de inscrição
24
Iniciar
23 Out 2023

Sobre o que é este estudo?

This study is about a new cream, called SXR1096, that we hope might help people with Netherton syndrome. Netherton syndrome is a rare genetic skin condition that can cause red, flaky skin, severe itching, and hair problems. We are testing this cream for the very first time in people, so it's an important early step in seeing if it could become a new treatment.

Our main aims are to find out two things: first, how safe the cream is to use, and second, if it actually improves the skin symptoms caused by Netherton syndrome. To do this, some people in the study will get the new SXR1096 cream, and others will get a 'dummy' cream, which looks and feels the same but doesn't have any active medicine. This helps us understand if any improvements are genuinely due to the new cream.

We will be carefully monitoring participants for any side effects or changes in their health. We'll also be looking closely at their skin using special assessment tools to see how much their skin redness, flaking, and itching improve. We'll also measure things like how much water their skin loses and the skin's pH balance. This detailed information will help us understand if SXR1096 cream could be a safe and effective treatment for Netherton syndrome in the future.

Pontos principais

  • This study is testing a new cream, SXR1096, for Netherton syndrome.
  • It's the first time this cream will be used in people.
  • The main goals are to check for safety and see if skin symptoms improve.
  • Participants will apply two different creams, one with medicine, one without.
  • Regular clinic visits will monitor your health and skin condition.
  • Você pode se retirar do estudo a qualquer momento sem afetar seu atendimento.

Quem pode ser elegível?

To be able to take part in this study, you need to be at least 18 years old. There's no upper age limit, so adults of any age are welcome to inquire. The study is open to both men and women.

The most important requirement is that you have a diagnosis of Netherton syndrome. The research team will also check other health factors to make sure that taking part in the study is safe for you. They will explain these in more detail if you are interested.

Este estudo pode ser adequado para você?

Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.

  1. Você tem 18 anos ou mais?
  2. Do you have a diagnosis of Netherton syndrome?
  3. Are you able to attend clinic appointments regularly?
  4. Are you willing to apply creams to your skin as instructed?
Responda a todas as perguntas para ver o seu resultado.

O que envolve a participação?

If you decide to take part, you'll be given two different creams to apply to different areas of your skin. One will contain the new medicine, and the other will be a 'dummy' cream with no medicine. Neither you nor the study team will know which cream is which, to ensure the results are as fair as possible. You'll use these creams for a set period of time.

Throughout the study, you'll have several visits to the clinic. At these visits, doctors and nurses will check your overall health, measure your vital signs (like blood pressure and temperature), and take blood samples. They will also carefully examine your skin, measure things like redness, flaking, and itching, and ask you about any side effects you might be having. These appointments will involve applying cream and undergoing skin assessments. The total length of your participation, including follow-up after stopping the cream, will be fully explained to you before you agree to join.

Riscos e benefícios potenciais

Taking part in any medical study has potential benefits and risks. A potential benefit of this study is that the new cream might improve symptoms of your Netherton syndrome, though this is not guaranteed as it's an early-stage trial. You'll also get close medical attention and monitoring throughout the study. Possible risks could include skin irritation or other side effects from the cream, or side effects from other study procedures like blood tests. All potential side effects will be explained in detail. Remember, you have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Localizações (4)

Algumas localizações dos sites são aproximadas. Estamos melhorando isso — por favor, verifique com a equipe de teste antes de viajar.
  • —
    Não verificado
    Alemanha
  • —
    Não verificado
    França
  • —
    Não verificado
    Áustria
  • —
    Não verificado
    Suécia

Perguntas frequentes

What is Netherton syndrome?

Netherton syndrome is a rare inherited skin condition that causes widespread red, flaky, and itchy skin, along with hair problems, from birth.

What does 'first-in-human' mean?

It means this is the first time the new cream, SXR1096, is being tested in people. It has been tested in labs and on animals before this stage.

O que é um 'placebo'?

A placebo is a 'dummy' treatment that looks exactly like the real medicine but contains no active ingredients. It helps us see if the new medicine really works better than no treatment.

Will I know if I'm getting the real cream or the placebo?

No, this is a 'double-blind' study, meaning neither you nor the doctors will know who is getting the active cream and who is getting the placebo until after the study has finished. This helps make the results fair.

Quanto tempo durará o estudo se eu participar?

The team will explain the exact duration, including how long you'll use the cream and any follow-up visits, during your first appointment. It typically involves several weeks or months.

Como saber mais

Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.

Interessado em participar?

Registre seu interesse

Compartilhe seus detalhes e a equipe de pesquisa para "A phase I/II, multicenter, randomized, double-blind, placebo…" entrará em contato com você se você for elegível. Sempre fale com seu médico antes de concordar em participar.

Discussão

Discussão da comunidade

Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.